Dr. Mallikarjun Vamadevappa Jali

About Doctor

Dr. Mallikarjun Vamadevappa Jali, MD, FRCP, FICP, FKSTA, D.Litt, is a renowned diabetologist with over 40 years of experience in diabetes care. He currently serves as the Medical Director & Chief Executive at KLES Dr. Prabhakar Kore Hospital & MRC in Belagavi. Dr. Jali has a distinguished career, having led South India's largest teaching hospital and spearheaded the establishment of a state-of-the-art cancer facility. He is an expert in diabetes care, geriatric diabetes, clinical trials, and healthcare strategy. Dr. Jali's key expertise includes establishing Centres of Excellence, leading Type 1 Diabetes programs, and integrating precision medicine in diabetes management. He treats conditions such as Type 1 and Type 2 Diabetes, Diabetic Neuropathy, Diabetic Retinopathy, Vitamin B12 Deficiency, and Osteoporosis in Diabetes. Dr. Mallikarjun V. Jali is affiliated with prestigious organizations such as the Indian Medical Association, American Diabetes Association, and Research Society for the Study of Diabetes in India. He has published numerous research articles, highlighting his contributions to the field of diabetology and internal medicine. Visit klehospital.org to learn more about his work and publications.

Past Experiences

• Medical Director & Chief Executive (Over one year as Director-Hospital Services (Administration) KLES Dr. Prabhakar Kore Hospital & Medical Research Centre, Belagavi Duration: January 2001 – November 2022 (20 years) Role: Led one of South India’s largest 2400-bed teaching hospitals. Oversaw strategic planning, hospital operations, academic integration, infrastructure development, and clinical governance.
• Medical Director & Chief Executive KLE Cancer Hospital (Under KAHER), Belagavi Duration: November 2022 – February 2025 (2 years 4 months) Role: Spearheaded the establishment and launch of a 300-bed state-of-the-art cancer facility, including a Bone Marrow Transplant Unit, Robotic Surgery, Radiation Oncology, and Genomic Precision Care services.
• Chief Medical Adviser KLE Academy of Higher Education & Research (KAHER), Belagavi Duration: Since March 2025 – Present Role: Advises on clinical excellence, healthcare strategy, faculty development, peripheral hospital planning, and research expansion across KLE’s network.
• Professor & Chief Diabetologist Department of Medicine, J.N. Medical College, KAHER, Belagavi Duration: 2000 – Present Role: Established the first comprehensive Diabetes Centre; focused on Type 1 and Type 2 diabetes care, clinical trials, community outreach, and postgraduate training.
• Founder & Principal Investigator KLE Diabetes Centre Duration: 2000 – Present Role: Founded a nationally recognised centre of excellence in diabetes; conducted over 20 international and national clinical trials, with special emphasis on Type 1 diabetes under global programmes.
• Coordinator & Faculty, Life for a Child Programme (Australia) & SWEET Project (European Union), Type 1 Diabetes Care (2005–Present).
• Author & Editor, "Diabetes-Doctor" Journal, Biannual Medical Publication (2000–Present).
• Clinical Trials Investigator, Over 20 international diabetes clinical trials (2000–2025).
• Coordinator, Cancer Screening & Awareness Initiatives, KLS GIT Collaboration, Belagavi (2021–2025).
• Advisor and coordinator, NAAC, NABL and NABH Accreditation & Quality Management, KLE Diabetes Centre, Belagavi (2020–present).
• Visiting Faculty & Keynote Speaker, Various National & International Diabetes and Oncology Conferences (2000–Present).
• Specialist Physician (Contractual) King Khalid Hospital, Saudi Arabia, Eastern Province (Gulf War period) Duration: 1990 – 1992 Role: Served in post-war humanitarian medical service; managed complex internal medicine cases during regional crisis. Allied Army Force led by the US Chief of Defence, served in Gulf War–related medical deployments.

Expertise

• Expert in Diabetes Care
• Geriatric Diabetes
• Diabetes Research
• Hospital Administration
• Clinical Trials
• Healthcare Strategy
• Skilled in establishing Centres of Excellence
• Leading Type 1 Diabetes programmes
• Integrating precision medicine in diabetes management